Anges MG Incorporated operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Anges MG Incorporated with three other
companies in this sector in Japan:
Onco Therapy Science, Inc
sales of 266.90 million Japanese Yen [US$2.39 million]
of which 100%
was Research & Development In Medical),
DNA Chip Research, Inc.
(284.16 million Japanese Yen [US$2.54 million]
Raqualia Pharma Incorporated
(705.24 million Japanese Yen [US$6.31 million]
Anges MG Incorporated reported sales of ¥514.27 million (US$4.60 million)
December of 2016.
increase of 19.6%
versus 2015, when the company's sales were ¥430.15 million.
Despite this increase, sales are still
below the level achieved in 2014, when Anges MG Incorporated
reported sales of ¥909.92 million.